Squadra Investimentos reduces Hapvida stake, citing significant capital loss

Brazilian asset manager Squadra has divested a portion of its position in healthcare provider Hapvida, publicly labeling the investment as its largest historical error. The stock has faced severe downward pressure, declining 57% year-to-date in 2026, reflecting ongoing operational or market-valuation challenges for the firm.